The objective of this study is to determine the safety, pharmacokinetic profile, immunoligc and virologic activity of Zintevir, an anti-HIV integrase inhibitor. Integrase inserts the genetic material of HIV into the host cell upon infection. This study will determine the activity of Zintevir to inhibit the enzyme integrase.
Showing the most recent 10 out of 370 publications